ASO Visual Abstract: A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

Kyushu Study Group of Treatment for Pancreatobiliary Cancer

doi:10.1245/s10434-022-12611-z

ASO Visual Abstract: A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

Kyushu Study Group of Treatment for Pancreatobiliary Cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	205-206
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	30
Issue number	1
DOIs	https://doi.org/10.1245/s10434-022-12611-z
Publication status	Published - Jan 1 2023

All Science Journal Classification (ASJC) codes

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-022-12611-z

Cite this

ASO Visual Abstract : A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement. / Kyushu Study Group of Treatment for Pancreatobiliary Cancer.

In: Annals of Surgical Oncology, Vol. 30, No. 1, 01.01.2023, p. 205-206.

Research output: Contribution to journal › Article › peer-review

@article{29af6ddc134b407d8912ce46335cd85e,

title = "ASO Visual Abstract: A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement",

author = "{Kyushu Study Group of Treatment for Pancreatobiliary Cancer} and Naoki Ikenaga and Yoshihiro Miyasaka and Takao Ohtsuka and Kohei Nakata and Tomohiko Adachi and Susumu Eguchi and Kazuyoshi Nishihara and Masafumi Inomata and Hiroshi Kurahara and Toru Hisaka and Hideo Baba and Hiroaki Nagano and Toshiharu Ueki and Hirokazu Noshiro and Shoji Tokunaga and Kousei Ishigami and Masafumi Nakamura",

year = "2023",

month = jan,

day = "1",

doi = "10.1245/s10434-022-12611-z",

language = "English",

volume = "30",

pages = "205--206",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - ASO Visual Abstract

T2 - A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

AU - Kyushu Study Group of Treatment for Pancreatobiliary Cancer

AU - Ikenaga, Naoki

AU - Miyasaka, Yoshihiro

AU - Ohtsuka, Takao

AU - Nakata, Kohei

AU - Adachi, Tomohiko

AU - Eguchi, Susumu

AU - Nishihara, Kazuyoshi

AU - Inomata, Masafumi

AU - Kurahara, Hiroshi

AU - Hisaka, Toru

AU - Baba, Hideo

AU - Nagano, Hiroaki

AU - Ueki, Toshiharu

AU - Noshiro, Hirokazu

AU - Tokunaga, Shoji

AU - Ishigami, Kousei

AU - Nakamura, Masafumi

PY - 2023/1/1

Y1 - 2023/1/1

UR - http://www.scopus.com/inward/record.url?scp=85143645295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143645295&partnerID=8YFLogxK

U2 - 10.1245/s10434-022-12611-z

DO - 10.1245/s10434-022-12611-z

M3 - Article

C2 - 36171527

AN - SCOPUS:85143645295

SN - 1068-9265

VL - 30

SP - 205

EP - 206

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 1

ER -

ASO Visual Abstract: A Prospective, Multicenter, Phase II, Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this